SE7609425L - Nytt antibiotiskt komplex - Google Patents
Nytt antibiotiskt komplexInfo
- Publication number
- SE7609425L SE7609425L SE7609425A SE7609425A SE7609425L SE 7609425 L SE7609425 L SE 7609425L SE 7609425 A SE7609425 A SE 7609425A SE 7609425 A SE7609425 A SE 7609425A SE 7609425 L SE7609425 L SE 7609425L
- Authority
- SE
- Sweden
- Prior art keywords
- gram
- complex
- new antibiotic
- antibiotic complex
- nihj
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title 1
- QRBLKGHRWFGINE-UGWAGOLRSA-N 2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2r,3s,4s,5s,6s)-3-[(2s,3r,4r,5s)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)- Chemical compound N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(C)=O)NC(=O)C(C)C(O)C(C)NC(=O)C(C(O[C@H]1[C@@]([C@@H](O)[C@H](O)[C@H](CO)O1)(C)O[C@H]1[C@@H]([C@](O)([C@@H](O)C(CO)O1)C(N)=O)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C QRBLKGHRWFGINE-UGWAGOLRSA-N 0.000 abstract 1
- 108010006654 Bleomycin Proteins 0.000 abstract 1
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- 201000000274 Carcinosarcoma Diseases 0.000 abstract 1
- LTQCLFMNABRKSH-UHFFFAOYSA-N Phleomycin Natural products N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(O)C)NC(=O)C(C)C(O)C(C)NC(=O)C(C(OC1C(C(O)C(O)C(CO)O1)OC1C(C(OC(N)=O)C(O)C(CO)O1)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C LTQCLFMNABRKSH-UHFFFAOYSA-N 0.000 abstract 1
- 108010035235 Phleomycins Proteins 0.000 abstract 1
- 241000700159 Rattus Species 0.000 abstract 1
- 241000203644 Streptoalloteichus hindustanus Species 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 229960001561 bleomycin Drugs 0.000 abstract 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/003—Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
- Y10S435/891—Streptomyces bikiniensia
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/608,494 US4051237A (en) | 1975-08-28 | 1975-08-28 | Glycopeptide antibiotics bu-2231 a and b and process for producing same |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7609425L true SE7609425L (sv) | 1977-03-01 |
SE432781B SE432781B (sv) | 1984-04-16 |
Family
ID=24436734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7609425A SE432781B (sv) | 1975-08-28 | 1976-08-25 | Forfarande for framstellning av ett nytt antibiotiskt glykopeptidkomplex av bleomycintyp med beteckningen bu-2231 och dess komponenter bu-2231a och bu-2231b genom odling av en stam av streptoalloteichus hindustanus |
Country Status (13)
Country | Link |
---|---|
US (1) | US4051237A (sv) |
JP (1) | JPS5231001A (sv) |
BE (1) | BE845513A (sv) |
CA (1) | CA1073386A (sv) |
DE (1) | DE2638766C2 (sv) |
DK (1) | DK141372B (sv) |
FR (1) | FR2321897A1 (sv) |
GB (1) | GB1539740A (sv) |
HU (1) | HU175049B (sv) |
IL (1) | IL50357A (sv) |
NL (1) | NL167199C (sv) |
SE (1) | SE432781B (sv) |
YU (1) | YU39084B (sv) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1540466A (en) * | 1975-10-29 | 1979-02-14 | Meiji Seika Kaisha | Antibiotic polypeptides sf-1771 and sf-1881-b and production thereof |
JPS55102596A (en) * | 1978-12-27 | 1980-08-05 | Meiji Seika Kaisha Ltd | Novel antibiotic substance, bn-183b substance, and its preparation |
US4246400A (en) * | 1979-07-13 | 1981-01-20 | Bristol-Myers Company | Tallysomycin compounds |
US4314028A (en) * | 1979-07-13 | 1982-02-02 | Bristol-Myers Company | Fermentation process for producing tallysomycin compounds |
FI903460A0 (fi) * | 1989-07-10 | 1990-07-09 | Bristol Myers Squibb Co | Antiviralt antibiotikum bu-3889v. |
ID18900A (id) * | 1996-11-21 | 1998-05-20 | Lilly Co Eli | Alkilasi menurun dari gliko peptida anti biotik |
US5952466A (en) * | 1997-11-12 | 1999-09-14 | Eli Lilly And Company | Reductive alkylation of glycopeptide antibiotics |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1038242A (en) * | 1963-03-05 | 1966-08-10 | Zaidan Hojin Biseibutsu | Bleomycin and processes for preparation thereof |
-
1975
- 1975-08-28 US US05/608,494 patent/US4051237A/en not_active Expired - Lifetime
-
1976
- 1976-08-10 CA CA258,766A patent/CA1073386A/en not_active Expired
- 1976-08-25 YU YU02078/76A patent/YU39084B/xx unknown
- 1976-08-25 BE BE170073A patent/BE845513A/xx not_active IP Right Cessation
- 1976-08-25 IL IL50357A patent/IL50357A/xx unknown
- 1976-08-25 SE SE7609425A patent/SE432781B/sv not_active IP Right Cessation
- 1976-08-25 DK DK384076AA patent/DK141372B/da not_active IP Right Cessation
- 1976-08-25 NL NL7609449.A patent/NL167199C/xx not_active IP Right Cessation
- 1976-08-27 DE DE2638766A patent/DE2638766C2/de not_active Expired
- 1976-08-27 JP JP51101723A patent/JPS5231001A/ja active Granted
- 1976-08-27 GB GB35740/76A patent/GB1539740A/en not_active Expired
- 1976-08-27 HU HU76BI549A patent/HU175049B/hu not_active IP Right Cessation
- 1976-08-27 FR FR7625923A patent/FR2321897A1/fr active Granted
Also Published As
Publication number | Publication date |
---|---|
GB1539740A (en) | 1979-01-31 |
YU207876A (en) | 1982-06-30 |
SE432781B (sv) | 1984-04-16 |
JPS5231001A (en) | 1977-03-09 |
NL7609449A (en) | 1977-03-02 |
DK141372C (sv) | 1980-09-01 |
YU39084B (en) | 1984-04-30 |
JPS5653318B2 (sv) | 1981-12-17 |
NL167199B (nl) | 1981-06-16 |
FR2321897A1 (fr) | 1977-03-25 |
FR2321897B1 (sv) | 1978-11-17 |
DE2638766C2 (de) | 1985-07-04 |
BE845513A (fr) | 1977-02-25 |
DE2638766A1 (de) | 1977-07-14 |
HU175049B (hu) | 1980-05-28 |
IL50357A0 (en) | 1976-10-31 |
IL50357A (en) | 1979-07-25 |
US4051237A (en) | 1977-09-27 |
NL167199C (nl) | 1981-11-16 |
DK141372B (da) | 1980-03-03 |
DK384076A (sv) | 1977-03-01 |
CA1073386A (en) | 1980-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Washington | Dilution susceptibility test: agar and macro-broth dilution procedures. | |
NZ180194A (en) | Antibiotic teichomycin a1 and a2 from actinoplanes teichomycetius nov.sp. atcc 31121 | |
IE812972L (en) | Actaplanin derivatives | |
ES8304203A1 (es) | Un procedimiento para la preparacion del complejo antibiotico a-4696. | |
IE782421L (en) | Pleuromutilin glycosides | |
GB8307847D0 (en) | Antibiotics l 17054 and l 17046 | |
MY100880A (en) | Antibiotic a 40926 complex and its pure factors pa, pb, a, b, and bo. | |
IE791948L (en) | A-21978 peptide antibiotics | |
SE7609425L (sv) | Nytt antibiotiskt komplex | |
ES2010729A6 (es) | Un procedimiento para prerparar un des-acil- antibiotico a 40926. | |
ES474327A1 (es) | Un procedimiento para producir el complejo antibiotico de desoxinarasina | |
MY100478A (en) | Antitumor antibiotic compound | |
SE7709234L (sv) | Antitumorantibiotika | |
IE36307L (en) | Antibiotic | |
Zamiri et al. | The sensitivity of diphtheria bacilli to eight antibiotics | |
AU527251B2 (en) | Antibiotic | |
NZ180208A (en) | Antibiotic from actinoplanes strains atcc 31,058 and 31,060 | |
EP0109750A3 (en) | Nargenicin c1 | |
ES8502729A1 (es) | "un procedimiento para producir el complejo antibiotico m 9226" | |
ES8306388A1 (es) | Procedimiento para preparar antibioticos y antitumorigenos de la familia de bleomicina-fleomicina, designados ll-b01208 y ll-b01208 y las sales de adicion de acido farmaceuticamente aceptables de los mismos. | |
ES8205809A1 (es) | Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas | |
ES8707251A1 (es) | Un metodo para producir n-desacetil-antibiotico tan-588 | |
IE831740L (en) | Antitumor antibiotic. | |
NZ180207A (en) | Antibiotic from actinoplanes strains atcc 31,058 and 31,060 | |
ZA816996B (en) | Antibiotic s/433 the process for preparing it and its use as an antitumor agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 7609425-9 Effective date: 19920306 Format of ref document f/p: F |